Curocell Inc. (KOSDAQ:372320)
South Korea · Delayed Price · Currency is KRW 28,600
+350 (1.24%)
At close: Jun 11, 2026
Curocell Market Cap
Curocell has a market cap or net worth of 438.51 billion as of June 12, 2026. Its market cap has increased by 5.57% in one year.
Market Cap
438.51B
Enterprise Value
470.50B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
28,600.00
Market Cap Chart
Since November 9, 2023, Curocell's market cap has increased from 295.40B to 438.51B, an increase of 48.45%. That is a compound annual growth rate of 16.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 438.51B | -32.41% |
| Dec 30, 2025 | 648.75B | 47.92% |
| Dec 30, 2024 | 438.58B | -10.00% |
| Dec 28, 2023 | 487.34B | 64.98% |
| Nov 9, 2023 | 295.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ROKIT Healthcare | 784.32B |
| Inventage Lab | 610.09B |
| IMBiologics | 387.13B |
| IntoCell | 363.53B |
| S.Biomedics | 359.17B |
| HansBiomed | 343.70B |
| Genome & Company | 266.01B |
| Kanaph Therapeutics | 249.42B |